// App-Quantinova.ai

: THE EFFECT OF OMECAMTIV MECARBIL IN HOSPITALIZED PATIENTS AS COMPARED WITH OUTPATIENTS: A PRESPECIFIED ANALYSIS OF GALACTIC-HF

Researchers

Presenter

  • Kieran F. Docherty

Principal Investigators

  • Brian Claggett

  • Rafael Diaz

  • G. Michael Felker

  • Marco Metra

  • Scott D. Solomon

  • Punag Divanji

  • Stephen B. Heitner

  • Stuart Kupfer

  • Fady I. Malik

  • John J.V. McMurray

  • John R. Teerlink

Medical Centers

  • British Heart Fndn Cardiovascular Res Ctr, Univ of Glasgow, Glasgow, United Kingdom

  • Cytokinetics, Incorporated, South San Francisco, CA, USA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • omecamtiv mecarbil (IV)

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT02929329

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved